Global Genomics Market

Genomics Market Size, Share, Growth Analysis, By Product & Service(Consumables and Reagents, Services, Instruments, Systems), By Technology(Sequencing, PCR, Flow Cytometry, Microarrays), By End Use(Government and Academic Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Others), By Application(Drug Discovery & Development, Diagnostics, Agriculture & Animal Research, Other Applications), By Study Type(Functional Genomics, Biomarker Discovery, Pathway Analysis, Epigenomics), By Region - Industry Forecast 2025-2032


Report ID: SQMIG35H2173 | Region: Global | Published Date: August, 2024
Pages: 165 | Tables: 121 | Figures: 77

Genomics Market Dynamics

Genomics Market Driver

NGS Applications Propel Genomics Market Growth 

  • Genomics market is being driven by increased application Next-Generation Sequencing (NGS) which is becoming more widely used in cancer research. Whole-genome sequencing, genome diversity inquiry, metagenomics, epigenetics, the discovery of non-coding RNAs and protein-binding sites, and gene-expression profiling by RNA sequencing are all applications of NGS technologies contributing to Genomics market growth.  

Boost in Government Funding Propels Genomics Market 

  • Funding for genomics activities is increasing to be supported by the government. The Economic Survey brings on record 200 percent increase in FDI in India pharma sector. According to the Union Budget 2022, ‘Genomics and Pharmaceuticals’ has been considered as emerging sectors by providing a encouraging environment for augmentation of domestic competence and encouraging research and development. This increase is expected to foster the growth of the global genomics market in the coming years. 

Restraints 

Shortage of Skilled Professionals and High Costs Challenge Genomics Market Growth 

  • There is demand present for genetic workforce. Potential limitation: Like most markets, the genomics market may be limited by the availability of competent personnel. Moreover, the expensive cost of genomic equipment and the problem of data storage due to sequenced data from 2023 to 2031 is expected to affect growth of this market. The integration of genomic approaches and technology in healthcare systems has the potential of enhancing safety, quality, efficiency, and cost-effectiveness. However, the fact that these benefits can be attained is highly dependent on the availability of skilled professionals. 

Data Integration Challenges in Genomics Due to Massive Data Generation 

  • A genetic examination of a single patient can produce around 1 terabyte of data in one encounter. Since genomics can be analysed before or during diagnosis and multiple times during treatment, and can be combined with lab data, clinical observations, tissue biopsy, morphologic data, and imaging data, the volume of new data generated necessitates developing roadmaps and big data solutions for effective integration.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Genomics Market size was valued at USD 27.81 Billion in 2022 and is poised to grow from USD 33.25 Billion in 2023 to USD 411.35 Billion by 2031, growing at a CAGR of 19.4% in the forecast period (2024-2031).

The genomics market is vast in nature with the presence of major companies in the market using operational strategies to promote their items and develop their market positions. One such strategy is to create new goods in collaboration with other firms in order to broaden their reach to end consumers. In August 2023, Genome Medical Announces the Acquisition of Gene Matters and the Closing of $60 Million Series C Financing. 'Illumina, Inc. (US) ', 'Thermo Fisher Scientific (US) ', 'Qiagen N.V. (Netherlands) ', 'BGI Group (China) ', 'F. Hoffmann-La Roche AG (Switzerland) ', 'Danaher Corporation (US) ', 'Pacific Biosciences of California, Inc. (US) ', 'Oxford Nanopore Technologies, Ltd. (United Kingdom) ', 'Agilent Technologies, Inc. (US) ', 'Eurofins Scientific SE (Luxembourg) ', 'Bio-Rad Laboratories, Inc. (US) ', 'Myriad Genetics, Inc. (US) ', 'Fluidigm Corporation (US) ', 'PerkinElmer, Inc. (US) ', 'Twist Bioscience Corporation (US) ', 'Natera, Inc. (US) ', 'Veracyte, Inc. (US) ', 'Personalis, Inc. (US) ', '10x Genomics, Inc. (US) ', 'Quest Diagnostics (US)'

Genomics market is being driven by increased application Next-Generation Sequencing (NGS) which is becoming more widely used in cancer research. Whole-genome sequencing, genome diversity inquiry, metagenomics, epigenetics, the discovery of non-coding RNAs and protein-binding sites, and gene-expression profiling by RNA sequencing are all applications of NGS technologies contributing to Genomics market growth.  

Switch to a customised Illumina global screening array (GSA) microarray instead of the Illumina OmniExpress chip. The OmniExpress chip from Illumina will be phased out in favour of the GSA chip. As a result, organisations like Ancestry.com will be obliged to convert to the GSA, acquire Thermo Fisher Scientific goods, or implement next-generation sequencing technology if they continue to utilize this equipment. 

North America dominated the market in terms of genomics market share in 2023 with a share of 42%. 65%, due mostly to the increased backing from research organizations and pharmaceutical companies. They keep changing the genetics, expression and health and therefore their influence makes genomics important in disease and drugs development. Some examples include the combination project initiated in January 2022 between Illumina, Inc. and Nashville Biosciences, LLC which is affiliated to the Vanderbilt University Medical Center. This collaboration will employ genomics for the purposes of drug discovery and create the best clinico-genomic resource.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Genomics Market

Report ID: SQMIG35H2173

$5,300
BUY NOW GET FREE SAMPLE